Wavegate Corporation raised $26M in a Series A funding round led by UCEA Capital Partners Ltd. to accelerate the development of their Ellipse™ platform for chronic pain solutions.
PRIVATEDec 11, 2024
Amount Raised
$26 Million
Round Type
Series A
Lake CharlesBiotechnologyHealthcareHealth CareMedical Device
Investors
UCEA Capital Partners Ltd.
Description
Wavegate Corporation has secured a $26 million Series A funding round led by UCEA Capital Partners Ltd. This financing will enhance the development of their cutting-edge Ellipse™ technology aimed at providing solutions for chronic pain patients.
Who to call at Wavegate, and when
A new round usually means Wavegate is about to hire and buy. The teams that reach out first get the meeting.
An alert the day Wavegate raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Wavegate, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Wavegate. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Wavegate
Location
Lake Charles, Louisiana, United States
About
Wavegate Corporation is focused on developing innovative therapeutic solutions for chronic pain patients through advanced neuromodulation technology. Their proprietary Ellipse™ platform utilizes StimuLux™ technology, enabling real-time adaptive stimulation based on spinal cord movement. The technology has received FDA Breakthrough Device designation, indicating its potential to significantly enhance pain management. Wavegate aims to improve patient outcomes by offering consistent pain relief tailored to individual activities.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Wavegate raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.